Literature DB >> 23539065

An observational and descriptive study of the epidemiology of and therapeutic approach to onychomycosis in dermatology offices in Brazil.

Nilton Di Chiacchio1, Maria Victoria Suarez, Celso Luís Madeira, Walter Refkalefsky Loureiro.   

Abstract

BACKGROUND: Onychomycosis is a type of fungal infection that accounts for over 50% of all onycopathies. Some authors consider superficial mycosis the most difficult to be treated. Very few studies have been carried out in order to assess the epidemiology of onychomycosis in Brazil.
OBJECTIVE: To describe the epidemiological profile of onychomycosis in Brazilian dermatology offices and to assess the etiology of the disease, how often mycosis exams are requested, and the treatment adopted.
METHODS: A descriptive, observational study was carried out between May and July, 2010. Thirty-eight dermatologists from different Brazilian regions participated in the study, and 7,852 patients with any skin diseases who had all of their nails examined were included in the study.
RESULTS: Of the 7,852 patients, 28.3% were clinically diagnosed as having onychomycosis. Women over 45 years old who practiced exercises or with a personal history of the disease showed greater likelihood of having onychomycosis. The disease was most seen in the feet, and the majority of cases involved the hallux. On the hands, the index finger was the most affected. Mycosis exams were not requested for all clinically suspected cases. When exams were done, results showed that the most common fungus was Trichophyton rubrum. The most common clinical lesion was distal-lateral. The most prescribed topical treatments were amorolfine and ciclopirox olamine, while systemic treatments included fluconazole and terbinafine.
CONCLUSION: This study was important to describe the epidemiological behavior of onychomycosis in Brazilian dermatology offices and to determine important risk factors, such as gender, age, practice of exercises, personal history of the disease, and comorbidities.

Entities:  

Mesh:

Year:  2013        PMID: 23539065

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  7 in total

1.  Superficial Fungal Infections in a French Teaching Hospital in Grenoble Area: Retrospective Study on 5470 Samples from 2001 to 2011.

Authors:  O Faure-Cognet; H Fricker-Hidalgo; H Pelloux; M T Leccia
Journal:  Mycopathologia       Date:  2015-10-09       Impact factor: 2.574

2.  A retrospective study of cutaneous fungal infections in patients referred to Imam Reza Hospital of Mashhad, Iran during 2000-2011.

Authors:  F Berenji; M Mahdavi Sivaki; F Sadabadi; Z Andalib Aliabadi; M Ganjbakhsh; M Salehi
Journal:  Curr Med Mycol       Date:  2016-03

3.  Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic.

Authors:  Flavia F Veiga; Marina C Gadelha; Marielen R T da Silva; Maiara I Costa; Brenda Kischkel; Lidiane V de Castro-Hoshino; Francielle Sato; Mauro L Baesso; Morgana F Voidaleski; Vanessa Vasconcellos-Pontello; Vânia A Vicente; Marcos L Bruschi; Melyssa Negri; Terezinha I E Svidzinski
Journal:  Front Microbiol       Date:  2018-04-25       Impact factor: 5.640

4.  Prevalence of dermatoses in patients referred for evaluation in an outpatient clinic of specialties.

Authors:  João Avancini; Paola Zucchi
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

5.  Prevalence, Risk Factors, and Spectrum of Fungi in Patients with Onychomycosis in Addis Ababa, Ethiopia: A Prospective Study.

Authors:  Adane Bitew; Sinknesh Wolde
Journal:  J Trop Med       Date:  2019-06-04

6.  Human Nails Permeation of an Antifungal Candidate Hydroalcoholic Extract from the Plant Sapindus saponaria L. Rich in Saponins.

Authors:  Vanessa Mendes; Flávia Franco Veiga; Lidiane Vizioli de Castro-Hoshino; Francielle Sato; Mauro Luciano Baesso; Beatriz Vesco; Elton Cruz; Izabel Cristina Piloto Ferreira; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

Review 7.  Spotlight on tavaborole for the treatment of onychomycosis.

Authors:  Sphoorthi Jinna; Justin Finch
Journal:  Drug Des Devel Ther       Date:  2015-11-20       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.